The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...
The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to prescribe controlled substances via telemedicine without first performing an in-person visit. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback